HCT Stock Overview
Holista CollTech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Holista Colltech Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.022 |
52 Week High | AU$0.026 |
52 Week Low | AU$0.004 |
Beta | 0.078 |
11 Month Change | 22.22% |
3 Month Change | 340.00% |
1 Year Change | 120.00% |
33 Year Change | -62.07% |
5 Year Change | -62.71% |
Change since IPO | -89.77% |
Recent News & Updates
Recent updates
Shareholder Returns
HCT | AU Personal Products | AU Market | |
---|---|---|---|
7D | 0% | -0.4% | -0.008% |
1Y | 120.0% | 75.4% | 15.0% |
Return vs Industry: HCT exceeded the Australian Personal Products industry which returned 75% over the past year.
Return vs Market: HCT exceeded the Australian Market which returned 15.1% over the past year.
Price Volatility
HCT volatility | |
---|---|
HCT Average Weekly Movement | n/a |
Personal Products Industry Average Movement | 5.9% |
Market Average Movement | 8.7% |
10% most volatile stocks in AU Market | 16.7% |
10% least volatile stocks in AU Market | 3.6% |
Stable Share Price: HCT's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine HCT's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | n/a | www.holistaco.com |
Holista CollTech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Food Ingredients, and Infection Control Solutions segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; infection control solutions; and healthy food ingredients, including low-glycemic index (GI) bread, noodles/pasta, and flatbreads, as well as low-calorie/low-GI sugar substitutes.
Holista Colltech Limited Fundamentals Summary
HCT fundamental statistics | |
---|---|
Market cap | AU$5.85m |
Earnings (TTM) | -AU$4.64m |
Revenue (TTM) | AU$5.46m |
1.1x
P/S Ratio-1.3x
P/E RatioIs HCT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HCT income statement (TTM) | |
---|---|
Revenue | AU$5.46m |
Cost of Revenue | AU$3.20m |
Gross Profit | AU$2.26m |
Other Expenses | AU$6.89m |
Earnings | -AU$4.64m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.017 |
Gross Margin | 41.33% |
Net Profit Margin | -84.97% |
Debt/Equity Ratio | -35.9% |
How did HCT perform over the long term?
See historical performance and comparison